Smouldering retinopathy of prematurity: a case treated by multiple antivascular endothelial growth factor therapy. [electronic resource]
Producer: 20170227ISSN:- 1757-790X
- Angiogenesis Inhibitors -- therapeutic use
- Bevacizumab -- therapeutic use
- Combined Modality Therapy
- Female
- Humans
- Infant
- Laser Therapy
- Ranibizumab -- therapeutic use
- Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
- Recurrence
- Retinopathy of Prematurity -- diagnosis
- Treatment Outcome
- Vitrectomy
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.